◆
Synthetic analog of tuftsin providing profound, non-sedating anxiety and stress reduction.
Dose ranges reflect commonly studied amounts in published research models. This is not medical advice. For research use only. Not for human consumption.
Protocol Comparison
Research Dose Reference
Available in 10 mg
SELANK
Cognitive
Research dose range
0 mcg125 mcg250 mcg375 mcg500 mcg
Standard research range
200 - 350 mcg
Standard research concentration for active stress attenuation and mental stability.
Research focus
Non-sedating emotional stability & GABA balance
Observed window
14-21 days active cycle
Administration
1-2x daily laboratory protocol
Primary pathway
Tuftsin analog / GABA-A modulation / Enkephalin protection
Dosing referenced from published peer-reviewed Russian clinical literature. For laboratory research only.
PROTOCOL BENEFITS
Engineered Outcomes
GABA-A ModulationNon-Addictive AnxiolyticTuftsin Analog
◆
Promotes positive GABA-A receptor modulation without tolerance, lethargy, or dependence.
◆
Protects enkephalins from enzymatic breakdown, supporting natural mood and emotional stability.
SCIENCE
How It Works.
Selank is a heptapeptide analog of the endogenous tetrapeptide tuftsin, developed to produce sustained anxiolytic and cognitive-enhancing actions. By binding to allosteric sites on GABA-A receptors, it modulates chloride ion conductance naturally.
In addition, Selank inhibits enkephalin-degrading enzymes in blood plasma, prolonging the half-life of endogenous opioid peptides that regulate emotional equilibrium, resulting in calmness without cognitive blunting or sedation.
WHAT TO EXPECT
Anxiolytic and stress-moderating effects are noticeable within 15–45 minutes. Emotional balance and memory recall under stress are assessed over 2–3 week periods.
PROTOCOL NOTE
Available in 10 mg sterile vials. For laboratory research only.
FAQ
Protocol Questions
What differentiates Selank's mechanism from conventional anxiolytics?+
Selank acts as an allosteric modulator of GABA-A receptors and inhibits enkephalin-degrading enzymes, promoting calmness and focus without sedation, motor impairment, or dependence.
What clinical evidence exists for Selank?+
Clinical trials conducted by the Russian Academy of Sciences demonstrate consistent anxiolytic efficacy in generalized anxiety and neurasthenia cohorts with an excellent tolerability profile.